Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Soft Tissue Neoplasms | 15 | 2024 | 1158 | 3.200 |
Why?
|
Sarcoma | 8 | 2024 | 1800 | 2.020 |
Why?
|
Vascular Malformations | 6 | 2021 | 468 | 1.470 |
Why?
|
Lipoma | 2 | 2023 | 293 | 1.280 |
Why?
|
Fibrosarcoma | 4 | 2023 | 308 | 1.130 |
Why?
|
Myofibromatosis | 2 | 2023 | 27 | 1.050 |
Why?
|
Hemangioma | 4 | 2023 | 727 | 0.990 |
Why?
|
Sarcoma, Clear Cell | 2 | 2022 | 72 | 0.930 |
Why?
|
GTP-Binding Protein alpha Subunits | 1 | 2023 | 102 | 0.840 |
Why?
|
Myxoma | 1 | 2023 | 114 | 0.830 |
Why?
|
Fibromatosis, Aggressive | 1 | 2023 | 126 | 0.800 |
Why?
|
Bone Neoplasms | 7 | 2024 | 2527 | 0.780 |
Why?
|
Adenomatous Polyposis Coli | 1 | 2023 | 219 | 0.770 |
Why?
|
Granuloma, Plasma Cell | 1 | 2022 | 80 | 0.760 |
Why?
|
Neoplasms, Neuroepithelial | 1 | 2021 | 42 | 0.750 |
Why?
|
Sarcoma, Synovial | 2 | 2020 | 153 | 0.720 |
Why?
|
Tandem Repeat Sequences | 1 | 2021 | 180 | 0.710 |
Why?
|
Hemangioendothelioma, Epithelioid | 4 | 2023 | 54 | 0.670 |
Why?
|
Protein-Tyrosine Kinases | 3 | 2023 | 2425 | 0.660 |
Why?
|
Neoplasms, Adipose Tissue | 1 | 2019 | 12 | 0.650 |
Why?
|
Child | 53 | 2024 | 80089 | 0.650 |
Why?
|
Giant Cell Tumor of Bone | 2 | 2018 | 118 | 0.640 |
Why?
|
Vascular Neoplasms | 1 | 2020 | 166 | 0.640 |
Why?
|
Desmoplastic Small Round Cell Tumor | 1 | 2018 | 33 | 0.630 |
Why?
|
Receptor Protein-Tyrosine Kinases | 3 | 2023 | 1626 | 0.620 |
Why?
|
Oncogene Proteins, Fusion | 7 | 2024 | 1608 | 0.620 |
Why?
|
Proto-Oncogene Proteins c-ret | 1 | 2020 | 225 | 0.610 |
Why?
|
Hamartoma | 2 | 2017 | 236 | 0.580 |
Why?
|
Neoplasms, Connective and Soft Tissue | 3 | 2023 | 34 | 0.560 |
Why?
|
Fibroma | 1 | 2018 | 190 | 0.560 |
Why?
|
Proto-Oncogene Proteins | 4 | 2022 | 4512 | 0.540 |
Why?
|
Neck | 1 | 2021 | 734 | 0.530 |
Why?
|
Child, Preschool | 33 | 2024 | 42193 | 0.520 |
Why?
|
High-Throughput Nucleotide Sequencing | 4 | 2024 | 3634 | 0.520 |
Why?
|
Gene Rearrangement | 5 | 2024 | 1125 | 0.520 |
Why?
|
Infant | 26 | 2024 | 36157 | 0.500 |
Why?
|
Head | 1 | 2021 | 922 | 0.490 |
Why?
|
Arteriovenous Malformations | 4 | 2020 | 396 | 0.450 |
Why?
|
Specimen Handling | 2 | 2020 | 701 | 0.440 |
Why?
|
Sequence Analysis, RNA | 1 | 2021 | 2013 | 0.430 |
Why?
|
Poly(A)-Binding Proteins | 1 | 2013 | 35 | 0.430 |
Why?
|
Mutation | 13 | 2024 | 30015 | 0.410 |
Why?
|
Pathology, Clinical | 1 | 2016 | 376 | 0.410 |
Why?
|
Neurofibrosarcoma | 2 | 2023 | 27 | 0.380 |
Why?
|
Receptor, trkA | 3 | 2023 | 159 | 0.380 |
Why?
|
Head and Neck Neoplasms | 2 | 2023 | 2894 | 0.380 |
Why?
|
Lymphoma, T-Cell, Peripheral | 1 | 2013 | 125 | 0.380 |
Why?
|
Bone Marrow Diseases | 1 | 2013 | 233 | 0.380 |
Why?
|
Repressor Proteins | 2 | 2021 | 2985 | 0.370 |
Why?
|
Hemangiosarcoma | 2 | 2023 | 215 | 0.370 |
Why?
|
Neoplasms, Muscle Tissue | 2 | 2021 | 67 | 0.360 |
Why?
|
RNA-Binding Protein EWS | 2 | 2024 | 210 | 0.350 |
Why?
|
Adolescent | 34 | 2024 | 88247 | 0.340 |
Why?
|
Carcinoma | 1 | 2021 | 2328 | 0.340 |
Why?
|
Biopsy, Fine-Needle | 2 | 2022 | 1118 | 0.330 |
Why?
|
Subcutaneous Tissue | 2 | 2021 | 132 | 0.330 |
Why?
|
Female | 61 | 2024 | 392203 | 0.320 |
Why?
|
Male | 49 | 2024 | 360402 | 0.300 |
Why?
|
Liver Neoplasms | 2 | 2021 | 4309 | 0.300 |
Why?
|
MAP Kinase Kinase 1 | 2 | 2020 | 332 | 0.300 |
Why?
|
Kidney Neoplasms | 2 | 2022 | 4252 | 0.300 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 3 | 2020 | 1745 | 0.290 |
Why?
|
Humans | 83 | 2024 | 760740 | 0.290 |
Why?
|
Fasciitis | 2 | 2019 | 67 | 0.280 |
Why?
|
Immunohistochemistry | 9 | 2024 | 11069 | 0.270 |
Why?
|
Neurofibromatosis 1 | 2 | 2023 | 560 | 0.270 |
Why?
|
Infant, Newborn | 11 | 2024 | 26183 | 0.270 |
Why?
|
Bone Marrow Cells | 1 | 2013 | 2409 | 0.250 |
Why?
|
Neoplasms, Second Primary | 1 | 2013 | 1051 | 0.240 |
Why?
|
Ubiquitin Thiolesterase | 2 | 2019 | 455 | 0.240 |
Why?
|
Sarcoma, Alveolar Soft Part | 1 | 2024 | 43 | 0.230 |
Why?
|
Neoplasm Recurrence, Local | 7 | 2023 | 9277 | 0.230 |
Why?
|
In Situ Hybridization, Fluorescence | 4 | 2024 | 2509 | 0.230 |
Why?
|
Nevus, Blue | 1 | 2024 | 43 | 0.230 |
Why?
|
Perivascular Epithelioid Cell Neoplasms | 1 | 2024 | 77 | 0.220 |
Why?
|
Oncogene Fusion | 2 | 2021 | 81 | 0.220 |
Why?
|
Brain Neoplasms | 2 | 2022 | 9026 | 0.220 |
Why?
|
Diagnosis, Differential | 8 | 2024 | 12966 | 0.210 |
Why?
|
Referral and Consultation | 1 | 2016 | 3599 | 0.210 |
Why?
|
Nuclear Receptor Coactivator 2 | 1 | 2022 | 40 | 0.210 |
Why?
|
Bone Marrow | 1 | 2013 | 2909 | 0.210 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 2 | 2023 | 183 | 0.210 |
Why?
|
Adenomatous Polyposis Coli Protein | 1 | 2023 | 180 | 0.210 |
Why?
|
Neoplasm Proteins | 2 | 2024 | 3607 | 0.210 |
Why?
|
Skin Neoplasms | 3 | 2024 | 5811 | 0.210 |
Why?
|
Dyskeratosis Congenita | 1 | 2023 | 73 | 0.210 |
Why?
|
Nephroma, Mesoblastic | 1 | 2022 | 24 | 0.200 |
Why?
|
Nose Neoplasms | 2 | 2015 | 249 | 0.200 |
Why?
|
Endodermal Sinus Tumor | 1 | 2022 | 53 | 0.200 |
Why?
|
Neoplasms, Connective Tissue | 1 | 2021 | 36 | 0.190 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2024 | 318 | 0.190 |
Why?
|
Necrosis | 2 | 2023 | 1610 | 0.190 |
Why?
|
Hemangioendothelioma | 1 | 2022 | 111 | 0.190 |
Why?
|
Nerve Sheath Neoplasms | 1 | 2023 | 170 | 0.190 |
Why?
|
Receptor, TIE-2 | 1 | 2021 | 176 | 0.190 |
Why?
|
Diarrhea, Infantile | 1 | 2021 | 100 | 0.190 |
Why?
|
Lip | 1 | 2022 | 197 | 0.180 |
Why?
|
Hypertension, Portal | 1 | 2023 | 227 | 0.180 |
Why?
|
Malabsorption Syndromes | 1 | 2021 | 135 | 0.180 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2013 | 4365 | 0.180 |
Why?
|
Granuloma, Pyogenic | 1 | 2020 | 47 | 0.170 |
Why?
|
Homeodomain Proteins | 3 | 2024 | 2413 | 0.170 |
Why?
|
Endothelial Cells | 3 | 2022 | 3550 | 0.170 |
Why?
|
Disorders of Sex Development | 1 | 2021 | 128 | 0.170 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 2 | 2021 | 899 | 0.170 |
Why?
|
Codon | 1 | 2021 | 600 | 0.170 |
Why?
|
Myofibroma | 1 | 2019 | 45 | 0.170 |
Why?
|
Teratoma | 1 | 2022 | 404 | 0.160 |
Why?
|
Prognosis | 9 | 2020 | 29601 | 0.160 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2013 | 4570 | 0.160 |
Why?
|
Oncogenes | 2 | 2022 | 1220 | 0.160 |
Why?
|
Genital Neoplasms, Female | 1 | 2024 | 532 | 0.160 |
Why?
|
Sarcoma, Kaposi | 1 | 2022 | 374 | 0.160 |
Why?
|
Metabolism, Inborn Errors | 1 | 2021 | 284 | 0.160 |
Why?
|
Neurofibromin 1 | 1 | 2020 | 190 | 0.160 |
Why?
|
Eye Abnormalities | 1 | 2021 | 242 | 0.150 |
Why?
|
Cartilage Diseases | 1 | 2020 | 157 | 0.150 |
Why?
|
beta Catenin | 1 | 2023 | 1039 | 0.150 |
Why?
|
Salivary Gland Neoplasms | 1 | 2022 | 304 | 0.150 |
Why?
|
Macrophage Colony-Stimulating Factor | 1 | 2018 | 186 | 0.150 |
Why?
|
WT1 Proteins | 1 | 2018 | 184 | 0.150 |
Why?
|
Parotid Neoplasms | 1 | 2019 | 157 | 0.150 |
Why?
|
Resource Allocation | 1 | 2020 | 350 | 0.150 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2023 | 732 | 0.150 |
Why?
|
Stem Cell Niche | 1 | 2021 | 344 | 0.140 |
Why?
|
Solitary Fibrous Tumors | 1 | 2018 | 67 | 0.140 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2022 | 491 | 0.140 |
Why?
|
Lymphatic Diseases | 1 | 2018 | 320 | 0.140 |
Why?
|
Liposarcoma | 1 | 2019 | 289 | 0.140 |
Why?
|
Scalp | 1 | 2019 | 389 | 0.140 |
Why?
|
Wnt Proteins | 1 | 2021 | 718 | 0.140 |
Why?
|
Atrial Septum | 1 | 2017 | 60 | 0.140 |
Why?
|
Hamartoma Syndrome, Multiple | 1 | 2017 | 114 | 0.130 |
Why?
|
Adipocytes | 1 | 2023 | 1187 | 0.130 |
Why?
|
Reoperation | 2 | 2024 | 4300 | 0.130 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2024 | 955 | 0.130 |
Why?
|
Young Adult | 16 | 2024 | 59191 | 0.130 |
Why?
|
Adult | 22 | 2024 | 220995 | 0.130 |
Why?
|
Appendix | 1 | 2017 | 109 | 0.130 |
Why?
|
Information Dissemination | 1 | 2024 | 1126 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-sis | 1 | 2017 | 255 | 0.130 |
Why?
|
Leg Injuries | 1 | 2017 | 179 | 0.130 |
Why?
|
Muscular Diseases | 1 | 2020 | 552 | 0.130 |
Why?
|
Congenital Abnormalities | 1 | 2020 | 709 | 0.130 |
Why?
|
Exons | 1 | 2021 | 2381 | 0.120 |
Why?
|
GTP Phosphohydrolases | 1 | 2018 | 517 | 0.120 |
Why?
|
Endemic Diseases | 1 | 2016 | 191 | 0.120 |
Why?
|
Skull | 1 | 2019 | 818 | 0.120 |
Why?
|
Rhabdomyosarcoma | 1 | 2018 | 358 | 0.120 |
Why?
|
Precancerous Conditions | 1 | 2022 | 982 | 0.120 |
Why?
|
Phosphoprotein Phosphatases | 1 | 2016 | 328 | 0.120 |
Why?
|
Upper Extremity | 1 | 2019 | 658 | 0.110 |
Why?
|
Diarrhea | 1 | 2021 | 1317 | 0.110 |
Why?
|
Glycoproteins | 1 | 2021 | 2200 | 0.110 |
Why?
|
Enterocolitis, Necrotizing | 1 | 2017 | 326 | 0.110 |
Why?
|
Meningioma | 1 | 2021 | 1215 | 0.100 |
Why?
|
Neoplasms | 4 | 2024 | 22131 | 0.100 |
Why?
|
Liver Diseases | 1 | 2021 | 1297 | 0.100 |
Why?
|
Liver Transplantation | 1 | 2024 | 2328 | 0.100 |
Why?
|
Meningeal Neoplasms | 1 | 2021 | 1245 | 0.100 |
Why?
|
Chordoma | 1 | 2015 | 347 | 0.100 |
Why?
|
Lower Extremity | 1 | 2020 | 1200 | 0.100 |
Why?
|
Neurilemmoma | 1 | 2017 | 524 | 0.100 |
Why?
|
Skin Diseases | 1 | 2020 | 1094 | 0.100 |
Why?
|
PTEN Phosphohydrolase | 1 | 2017 | 1113 | 0.100 |
Why?
|
Hypoplastic Left Heart Syndrome | 1 | 2017 | 594 | 0.090 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2021 | 2057 | 0.090 |
Why?
|
Elasticity Imaging Techniques | 1 | 2016 | 391 | 0.090 |
Why?
|
Lung | 2 | 2022 | 9999 | 0.090 |
Why?
|
Histones | 2 | 2023 | 2577 | 0.090 |
Why?
|
Pancreatitis | 1 | 2018 | 1097 | 0.090 |
Why?
|
Osteochondroma | 1 | 2011 | 44 | 0.090 |
Why?
|
Cytogenetic Analysis | 1 | 2011 | 270 | 0.090 |
Why?
|
Kaplan-Meier Estimate | 2 | 2019 | 6473 | 0.090 |
Why?
|
Genomics | 5 | 2024 | 5822 | 0.080 |
Why?
|
Fatty Liver | 1 | 2016 | 787 | 0.080 |
Why?
|
DNA Methylation | 2 | 2023 | 4392 | 0.080 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2011 | 418 | 0.080 |
Why?
|
Protein Kinase Inhibitors | 2 | 2022 | 5672 | 0.080 |
Why?
|
Ultrasonography, Prenatal | 1 | 2017 | 1754 | 0.080 |
Why?
|
Cell Proliferation | 1 | 2024 | 10429 | 0.080 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2011 | 638 | 0.080 |
Why?
|
Follow-Up Studies | 6 | 2020 | 39062 | 0.070 |
Why?
|
Molecular Biology | 2 | 2022 | 575 | 0.070 |
Why?
|
Malaria, Falciparum | 1 | 2016 | 1076 | 0.070 |
Why?
|
Retrospective Studies | 10 | 2024 | 80583 | 0.070 |
Why?
|
Glioma | 1 | 2022 | 3452 | 0.070 |
Why?
|
Molecular Targeted Therapy | 3 | 2024 | 2812 | 0.070 |
Why?
|
Proteins | 1 | 2021 | 6030 | 0.070 |
Why?
|
Syndrome | 2 | 2024 | 3268 | 0.070 |
Why?
|
Biopsy | 4 | 2020 | 6763 | 0.070 |
Why?
|
Plasmodium falciparum | 1 | 2016 | 1740 | 0.070 |
Why?
|
Ovarian Neoplasms | 1 | 2022 | 4849 | 0.060 |
Why?
|
Myelodysplastic Syndromes | 1 | 2015 | 1394 | 0.060 |
Why?
|
Translocation, Genetic | 1 | 2011 | 1392 | 0.060 |
Why?
|
Muscle, Skeletal | 1 | 2020 | 4947 | 0.060 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2015 | 2916 | 0.060 |
Why?
|
Pain | 1 | 2020 | 5062 | 0.060 |
Why?
|
Sex Factors | 1 | 2018 | 10549 | 0.060 |
Why?
|
Liver | 2 | 2021 | 7512 | 0.060 |
Why?
|
Biomedical Research | 1 | 2020 | 3426 | 0.060 |
Why?
|
Middle Aged | 10 | 2024 | 220603 | 0.060 |
Why?
|
Pancreatic Neoplasms | 2 | 2021 | 5369 | 0.060 |
Why?
|
Endothelium, Lymphatic | 1 | 2024 | 63 | 0.060 |
Why?
|
Epithelioid Cells | 1 | 2024 | 60 | 0.060 |
Why?
|
Melanoma | 1 | 2022 | 5696 | 0.060 |
Why?
|
Primary Graft Dysfunction | 1 | 2024 | 111 | 0.050 |
Why?
|
Reproducibility of Results | 1 | 2021 | 20077 | 0.050 |
Why?
|
Angiomyolipoma | 1 | 2024 | 188 | 0.050 |
Why?
|
Leukoplakia, Oral | 1 | 2023 | 77 | 0.050 |
Why?
|
Lymphangioleiomyomatosis | 1 | 2024 | 204 | 0.050 |
Why?
|
Plasma Cell Granuloma, Pulmonary | 1 | 2021 | 12 | 0.050 |
Why?
|
Proportional Hazards Models | 1 | 2016 | 12448 | 0.050 |
Why?
|
S100 Proteins | 1 | 2022 | 217 | 0.050 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2023 | 257 | 0.050 |
Why?
|
Postoperative Complications | 1 | 2024 | 15609 | 0.050 |
Why?
|
Membrane Proteins | 1 | 2018 | 7847 | 0.050 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2022 | 167 | 0.050 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2024 | 693 | 0.050 |
Why?
|
Polymerase Chain Reaction | 2 | 2021 | 6074 | 0.050 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2024 | 561 | 0.040 |
Why?
|
Salivary Glands | 1 | 2022 | 229 | 0.040 |
Why?
|
Genitalia | 1 | 2021 | 113 | 0.040 |
Why?
|
Gene Fusion | 1 | 2023 | 356 | 0.040 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2024 | 8542 | 0.040 |
Why?
|
Base Sequence | 2 | 2022 | 12420 | 0.040 |
Why?
|
Public Opinion | 1 | 2024 | 484 | 0.040 |
Why?
|
Tissue Banks | 1 | 2020 | 184 | 0.040 |
Why?
|
Germ Cells | 1 | 2023 | 634 | 0.040 |
Why?
|
Phenotype | 3 | 2021 | 16572 | 0.040 |
Why?
|
Dissection | 1 | 2020 | 297 | 0.040 |
Why?
|
Sclerotherapy | 1 | 2019 | 182 | 0.040 |
Why?
|
STAT6 Transcription Factor | 1 | 2018 | 194 | 0.040 |
Why?
|
Gastric Mucosa | 1 | 2021 | 603 | 0.040 |
Why?
|
Aged | 6 | 2021 | 169092 | 0.040 |
Why?
|
Microtubule-Associated Proteins | 1 | 2022 | 1074 | 0.040 |
Why?
|
Tongue | 1 | 2020 | 403 | 0.040 |
Why?
|
Gene Expression Regulation | 1 | 2015 | 11874 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2021 | 13383 | 0.040 |
Why?
|
Disease-Free Survival | 2 | 2019 | 6807 | 0.040 |
Why?
|
Combined Modality Therapy | 2 | 2019 | 8516 | 0.030 |
Why?
|
Genetic Heterogeneity | 1 | 2020 | 733 | 0.030 |
Why?
|
Rare Diseases | 1 | 2021 | 622 | 0.030 |
Why?
|
Antigens, CD34 | 1 | 2018 | 658 | 0.030 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2024 | 3599 | 0.030 |
Why?
|
Cohort Studies | 1 | 2018 | 41464 | 0.030 |
Why?
|
Point Mutation | 1 | 2021 | 1595 | 0.030 |
Why?
|
Reticulin | 1 | 2015 | 19 | 0.030 |
Why?
|
Recurrence | 2 | 2020 | 8426 | 0.030 |
Why?
|
Signal Transduction | 1 | 2018 | 23415 | 0.030 |
Why?
|
Fetal Heart | 1 | 2017 | 281 | 0.030 |
Why?
|
Comparative Genomic Hybridization | 1 | 2016 | 473 | 0.030 |
Why?
|
North America | 1 | 2018 | 1273 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2024 | 15250 | 0.030 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2024 | 2872 | 0.030 |
Why?
|
Neovascularization, Pathologic | 1 | 2024 | 2644 | 0.030 |
Why?
|
Ultrasonography | 2 | 2017 | 5965 | 0.030 |
Why?
|
Tumor Suppressor Proteins | 1 | 2024 | 2803 | 0.030 |
Why?
|
Fetus | 1 | 2021 | 1862 | 0.030 |
Why?
|
Graft Survival | 1 | 2024 | 3814 | 0.030 |
Why?
|
Survival Rate | 2 | 2019 | 12719 | 0.030 |
Why?
|
Transcription Factors | 2 | 2024 | 12116 | 0.030 |
Why?
|
Mitosis | 1 | 2018 | 1187 | 0.030 |
Why?
|
Glucocorticoids | 1 | 2021 | 2160 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2015 | 20556 | 0.020 |
Why?
|
Accidents, Traffic | 1 | 2017 | 816 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2021 | 2570 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 1 | 2019 | 3730 | 0.020 |
Why?
|
Graft Rejection | 1 | 2024 | 4438 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2019 | 2020 | 0.020 |
Why?
|
Alleles | 1 | 2021 | 6861 | 0.020 |
Why?
|
Ulna | 1 | 2011 | 134 | 0.020 |
Why?
|
Collagen | 1 | 2018 | 2634 | 0.020 |
Why?
|
Intestinal Mucosa | 1 | 2021 | 3031 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2024 | 5789 | 0.020 |
Why?
|
Boston | 1 | 2022 | 9313 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2024 | 7995 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2020 | 64572 | 0.020 |
Why?
|
Fibrosis | 1 | 2015 | 2047 | 0.020 |
Why?
|
Computational Biology | 1 | 2020 | 3509 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2024 | 16968 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 3 | 2020 | 36401 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2018 | 4910 | 0.020 |
Why?
|
Proteomics | 1 | 2020 | 3836 | 0.020 |
Why?
|
Autoimmune Diseases | 1 | 2018 | 2238 | 0.020 |
Why?
|
Genetic Variation | 1 | 2018 | 6561 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2018 | 11118 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2018 | 58919 | 0.010 |
Why?
|
Disease Progression | 1 | 2019 | 13495 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2019 | 11512 | 0.010 |
Why?
|
Inflammation | 1 | 2021 | 10759 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2016 | 12759 | 0.010 |
Why?
|
Age Factors | 1 | 2018 | 18381 | 0.010 |
Why?
|
Animals | 2 | 2024 | 168202 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2016 | 14649 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2020 | 17878 | 0.010 |
Why?
|
Prospective Studies | 1 | 2022 | 54364 | 0.010 |
Why?
|
Mice | 1 | 2024 | 81368 | 0.010 |
Why?
|
Pregnancy | 1 | 2017 | 29869 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2016 | 26065 | 0.010 |
Why?
|